Literature DB >> 30103173

Association between brain atrophy and cognitive motor interference in multiple sclerosis.

Giancarlo Coghe1, Giuseppe Fenu2, Lorena Lorefice2, Erica Zucca2, Micaela Porta3, Giuseppina Pilloni2, Federica Corona3, Jessica Frau2, Maria Giovanna Marrosu2, Massimiliano Pau3, Eleonora Cocco2.   

Abstract

INTRODUCTION: Cognitive motor interference (CMI) is performance impairment due to simultaneuous task execution and is measured using the dual task cost (DTC). No pathological feature of MS has to date been associated with CMI. AIM: To assess the relationship between brain volumes and CMI, as measured using the DTC, in a cross-sectional study.
METHODS: A group of persons with MS (pwMS) and an age- and sex-matched healthy control (HC) group underwent 3D gait analysis during using the dual task paradigm. Brain volumes were measured on T1-weighted gradient echo scans using SIENAX software. The relationships between brain volumes and the DTCs of spatial temporal parameters were evaluated using Pearson correlation. A multiple regression model was used to evaluate the ability to predict the DTC of cadence based on brain volume and grey matter (GM) volume.
RESULTS: Forty-four patients and 16 HCs underwent MRI and gait analysis. The mean expanded disability status scale (EDSS) was 2.4 ± 1.5. Significant relationships between brain volumes and DTC were found only in the pwMS group, with higher rho scores for the DTC of mean velocity, DTC of cadence, and DTC of stride time. A statistically significant regression equation with an R2 value of 0.684 was found using GM and Z-score on the Stroop test as predictors of the DTC of cadence (p < 0.001).
CONCLUSION: Brain atrophy, especially than in the GM, is a major determinant of DTC, although other pathological markers also contribute to CMI in patients with MS.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Brain atrophy; Cognitive motor interference; Dual task; Multiple sclerosis; Stroop color and word test

Mesh:

Year:  2018        PMID: 30103173     DOI: 10.1016/j.msard.2018.07.045

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  3 in total

Review 1.  Molecular biomarkers in multiple sclerosis.

Authors:  Tjalf Ziemssen; Katja Akgün; Wolfgang Brück
Journal:  J Neuroinflammation       Date:  2019-12-23       Impact factor: 8.322

2.  Cognitive Function and Whole-Brain MRI Metrics Are Not Associated with Mobility in Older Adults with Multiple Sclerosis.

Authors:  Jessica F Baird; Robert W Motl
Journal:  Int J Environ Res Public Health       Date:  2021-04-16       Impact factor: 3.390

3.  Significance of the Diagnosis of Executive Functions in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Aneta R Borkowska; Beata Daniluk; Katarzyna Adamczyk
Journal:  Int J Environ Res Public Health       Date:  2021-10-07       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.